Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of methylphenidate.

We are aware of a supply issue affecting one preparation of methylphenidate prolonged-release tablets, namely Xenidate XL 27 milligram tablets. We continue to work with the manufacturer to ensure the issue is resolved quickly. We currently expect further stock to be available in late July 2023. Alternative brands of methylphenidate prolonged-release tablets and other methylphenidate preparations continue to remain available.

The Department issued comprehensive communications to the National Health Service in May 2022 which included advice on equivalent alternative brands and how to manage affected patients during this time.